This research examines how scientists are developing new drugs to target RAS proteins, which are major drivers of various cancers. Once thought impossible to treat, these proteins are now becoming targetable through innovative drug development approaches. The study reviews various compounds that could potentially treat cancers caused by RAS mutations. Impacts on everyday life: – Provides hope for new treatments for previously difficult-to-treat cancers – Could lead to more effective and targeted cancer therapies with fewer side effects – May help extend survival rates for patients with RAS-mutated cancers – Could reduce healthcare costs through more effective treatments – Demonstrates progress in making ‘undruggable’ targets druggable, opening new possibilities for other diseases